Gastrointestinal Cancer News

A novel blood-based assay demonstrated the ability to detect five cancer types up to 4 years earlier than current screening methods, according to study results published in Nature Communications.

Raymond N. DuBois, MD, PhD, dean of Medical University of South Carolina’s College of Medicine, has been appointed director of MUSC Hollings Cancer Center.

Fox Chase Cancer Center announced several faculty appointments.

Hepatocellular carcinoma, the sixth most common cancer, accounts for 90% of primary liver cancers worldwide. Its incidence has tripled since the 1980s.

Edward Chu, MD, MMS, has been named director of Albert Einstein Cancer Center.

American Institute for Cancer Research awarded approximately $1.3 million in grants to support eight projects intended to improve the understanding of the effects of lifestyle factors on cancer prevention and survivorship.

The addition of pembrolizumab to first-line chemotherapy extended OS and PFS among patients with locally advanced or metastatic esophageal cancer, according to the agent’s manufacturer.

The combination of dabrafenib and trametinib appeared active among patients with BRAF V600E-mutated biliary tract cancer, according to results of an ongoing phase 2 basket trial published in The Lancet Oncology.

Aspirin may accelerate the progression of cancer among older people, according to results of a randomized study published in Journal of the National Cancer Institute.

Recent-onset diabetes accompanied by weight loss appeared to be associated with a substantially higher risk for developing pancreatic cancer, according to results of a retrospective cohort study published in JAMA Oncology.